Cooper Cos. (COO): Price and Financial Metrics
COO Price/Volume Stats
| Current price | $319.37 | 52-week high | $399.62 |
| Prev. close | $315.92 | 52-week low | $244.21 |
| Day low | $316.12 | Volume | 481,981 |
| Day high | $320.31 | Avg. volume | 291,785 |
| 50-day MA | $365.34 | Dividend yield | 0.02% |
| 200-day MA | $360.20 | Market Cap | 15.82B |
COO Stock Price Chart Interactive Chart >
COO POWR Grades
- Stability is the dimension where COO ranks best; there it ranks ahead of 82.72% of US stocks.
- COO's strongest trending metric is Stability; it's been moving up over the last 177 days.
- COO's current lowest rank is in the Momentum metric (where it is better than 6.97% of US stocks).
COO Stock Summary
- COOPER COMPANIES INC's stock had its IPO on January 1, 1986, making it an older stock than 93.16% of US equities in our set.
- COO's current price/earnings ratio is 59.16, which is higher than 90.35% of US stocks with positive earnings.
- The volatility of COOPER COMPANIES INC's share price is greater than that of merely 9.76% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to COOPER COMPANIES INC are CSL, ESI, XYL, ZD, and STE.
- Visit COO's SEC page to see the company's official filings. To visit the company's web site, go to www.coopercos.com.
COO Valuation Summary
- COO's price/earnings ratio is 59.2; this is 121.72% higher than that of the median Healthcare stock.
- COO's price/sales ratio has moved up 1.4 over the prior 243 months.
Below are key valuation metrics over time for COO.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| COO | 2023-09-22 | 4.6 | 2.2 | 59.2 | 39.0 |
| COO | 2023-09-21 | 4.6 | 2.2 | 59.1 | 39.0 |
| COO | 2023-09-20 | 4.7 | 2.2 | 60.6 | 39.8 |
| COO | 2023-09-19 | 4.7 | 2.2 | 60.6 | 39.8 |
| COO | 2023-09-18 | 4.8 | 2.2 | 60.7 | 39.9 |
| COO | 2023-09-15 | 4.8 | 2.3 | 61.6 | 40.4 |
COO Growth Metrics
- The 5 year net cashflow from operations growth rate now stands at -1.82%.
- Its 4 year net income to common stockholders growth rate is now at 4.24%.
- Its 3 year net income to common stockholders growth rate is now at 121.96%.
The table below shows COO's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 3,308.4 | 692.4 | 385.8 |
| 2022-06-30 | 3,219.5 | 736.2 | 430.6 |
| 2022-03-31 | 3,139.5 | 696.1 | 948 |
| 2021-12-31 | 3,029.2 | 756.9 | 938.9 |
| 2021-09-30 | 2,922.5 | 738.6 | 2,944.7 |
| 2021-06-30 | 2,845 | 782.4 | 2,915.6 |
COO's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- COO has a Quality Grade of C, ranking ahead of 72.46% of graded US stocks.
- COO's asset turnover comes in at 0.332 -- ranking 126th of 186 Medical Equipment stocks.
- KRMD, XENT, and BIOL are the stocks whose asset turnover ratios are most correlated with COO.
The table below shows COO's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-07-31 | 0.332 | 0.660 | 0.087 |
| 2021-04-30 | 0.339 | 0.648 | 0.093 |
| 2021-01-31 | 0.341 | 0.632 | 0.077 |
| 2020-10-31 | 0.366 | 0.631 | 0.079 |
| 2020-07-31 | 0.374 | 0.641 | 0.096 |
| 2020-04-30 | 0.399 | 0.651 | 0.122 |
COO Price Target
For more insight on analysts targets of COO, see our COO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $478.50 | Average Broker Recommendation | 1.63 (Moderate Buy) |
Cooper Cos. (COO) Company Bio
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company, publicly traded on the NYSE (NYSE:COO). With its headquarters in San Ramon, California, it has a workforce of more than 12,000 employees and consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI) which manufactures medical devices and fertility and genomic products for the women’s health care market. (Source:Wikipedia)
Latest COO News From Around the Web
Below are the latest news stories about COOPER COMPANIES INC that investors may wish to consider to help them evaluate COO as an investment opportunity.
Unveiling the Investment Potential of The Cooper Companies Inc (COO): A Comprehensive Analysis ...Delving into the financial growth, competitive edges, and market leadership of The Cooper Companies Inc (COO) |
CooperCompanies Announces Transfer of Stock Exchange Listing to NasdaqSAN RAMON, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that it will transfer the listing of its common stock from the New York Stock Exchange (“NYSE”) to the Nasdaq Stock Market (“Nasdaq”). Cooper expects to begin trading as a Nasdaq-listed company at market open on September 26, 2023, and will continue to trade under the symbol “COO.” “We are excited to join many of the world’s largest and most innovative companies on Nasdaq,” said Al White, President |
CooperCompanies to Present at the Baird Healthcare ConferenceSAN RAMON, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Baird Healthcare Conference on Wednesday, September 13, 2023. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled to begin at 1:25 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A replay of the event will be a |
Cord Blood Registry® Announces Thought Leadership Role at Cord Blood ConnectCooperSurgical, a global leader in fertility and women's health, announced that Cord Blood Registry® (CBR®) will have a key role in the upcoming Cord Blood Connect meeting from September 8th – 11th, which is the annual meeting of the Cord Blood Association. The Cord Blood Association is an international nonprofit organization that promotes both public and family newborn stem cell preservation and accelerates the use of cord blood and birthing tissues to benefit patients and advance medicine. |
Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)Key Insights Cooper Companies' estimated fair value is US$430 based on 2 Stage Free Cash Flow to Equity Cooper... |
COO Price Returns
| 1-mo | -15.54% |
| 3-mo | -16.70% |
| 6-mo | -14.45% |
| 1-year | 18.70% |
| 3-year | -4.37% |
| 5-year | 15.33% |
| YTD | -3.40% |
| 2022 | -21.06% |
| 2021 | 15.33% |
| 2020 | 13.10% |
| 2019 | 26.27% |
| 2018 | 16.84% |
COO Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching COO
Want to see what other sources are saying about Cooper Companies Inc's financials and stock price? Try the links below:Cooper Companies Inc (COO) Stock Price | Nasdaq
Cooper Companies Inc (COO) Stock Quote, History and News - Yahoo Finance
Cooper Companies Inc (COO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...